dsip sbir topics Air Force removes from SBIR/STTR solicitation | Kirk Macolini posted on the topic Funding Opportunities | SBIR

Retatrutide introduces a new safety signal, dysesthesia, present in one-fifth of patients at 12 mg, linked to glucagon activity

Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects

Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157

Jealous delusion: definition, causes, symptoms, and treatments Jealous delusion is a false belief that a partner is being unfaithful despite no evidence to confirm it

The cell suspension was incubated for 1 h at room temperature